CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$56.43 +0.43 (+0.77%)
As of: Sep 30, 2026 · 12:23 PM EDT

CRISPR Therapeutics AG (CRSP) EBIT Margin (2016 - 2026)

Updated

CRISPR Therapeutics AG (CRSP) reported EBIT Margin of -1151.84% for Q2 2026, up 24557.13 percentage points from -25708.97% a year earlier and up 7781.49 percentage points from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) EBIT Margin (2016 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, CRISPR Therapeutics AG's EBIT Margin came in at -3989.99%, down 2538.05 percentage points year-over-year; for FY2025, it was -18933.65%, down 17683.27 percentage points from FY2024.

  • EBIT Margin has a five-year change of +30361.90 percentage points (FY2020 to FY2025).
  • By year, EBIT Margin came in at -1250.38% in FY2024 (-1190.43 pp), -59.95% in FY2023 (+56130.45 pp), -56190.40% in FY2022 (-56231.23 pp) and 40.82% in FY2021 (+49336.37 pp).
  • The Q2 2026 figure ranks as the highest quarterly EBIT Margin since Q4 2024.
  • Year over year, EBIT Margin gained in five of the last seven quarters, with an average year-over-year change of +4651.21 percentage points.
  • The high point for year-over-year EBIT Margin in five years was Q4 2023 (a gain of 2192384.58 percentage points); the low point was Q4 2022 (a drop of 2191220.47 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -8933.33% (Q1 2026), -17912.50% (Q4 2025) and -14854.78% (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,151.84%
Mar 31, 2026 -8,933.33%
Dec 31, 2025 -17,912.50%
Sep 30, 2025 -14,854.78%
Jun 30, 2025 -25,708.97%
Mar 31, 2025 -17,158.84%
Dec 31, 2024 -180.96%
Sep 30, 2024 -18,294.02%
Jun 30, 2024 -29,257.25%
Mar 31, 2024 -27,894.25%
Dec 31, 2023 34.58%
Jun 30, 2023 -136.03%
Mar 31, 2023 -64.49%
Dec 31, 2022 -2,192,350.00%
Sep 30, 2022 -194,029.79%
Jun 30, 2022 -115,987.34%
Mar 31, 2022 -18,720.43%
Dec 31, 2021 -1,129.53%
Sep 30, 2021 -15,637.01%
Jun 30, 2021 84.67%
API Access

CRISPR Therapeutics AG EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEY